In 2021, semaglutide 2.4 mg became the most-effective GLP-1 RA approved for obesity management with 14.9% mean WL at 68 weeks vs
Li, W., Gu, Y., Liu, S., Ruan, F
BPC-157 and TB-500 Research: Complementary Pathway Studies in Cell Models The content, articles and product information provided on this website are strictly educational and informational
Continued research and clinical evaluation are required to fully elucidate the therapeutic potential of peptides for gastrointestinal health
Triglycerides Median triglyceride levels decreased significantly within each treatment group at week 36 (all p 0.05)
Levels below 0.5 indicate you are not consistently in ketosis, meaning carbohydrate intake may be too high or protein intake may be excessive enough to trigger gluconeogenesis